GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxes Health news and commentary from around the Web gathered by 51˶ staff Dec 06, 2023
Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
Year in Review: Obesity 2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI Dec 01, 2023
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Want Lower Obesity Drug Costs? Medicare Holds the Key Medicare coverage will catalyze market competition Nov 17, 2023
Mall Doc Kiosks; Gaza Hospital Stormed; Rationing Semaglutide by Lifestyle Health news and commentary from around the Web gathered by 51˶ staff Nov 16, 2023
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
Double Defibrillator More Effective for Obese Afib Patients Clinical trial affirms a better initial strategy Nov 12, 2023
Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meeting Delegates agree the current system is broken but disagree on the solution Nov 12, 2023
And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes Established weight loss and diabetes drug may extend reach to millions more Nov 11, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
Obesity Medication Type, Insurance Carrier Linked to Treatment Persistence Amount of weight lost by 6 months also played a role, according to a retrospective cohort study Oct 18, 2023
Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months Oct 17, 2023
Certain Factors Predict Weight Regain After Big Losses But even "regainers" still kept off most of the weight Oct 17, 2023
Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortality Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
Semaglutide's Weight-Loss Benefit Also Seen in Patients on Antidepressants Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials Oct 16, 2023
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risks Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Weight-Loss Drug Benefit Spans HFpEF, HFmrEF STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
Are Obesity Drugs for Adolescents Cost-Effective? Despite the effectiveness of these medications, costs are a major barrier Sep 30, 2023
MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraising 51˶ reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
The GLP-1 Agonist Plateau No One's Talking About Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
